China Insurance Companies Eye Health Care Institutions
This article was originally published in PharmAsia News
Executive Summary
The health care industry has always considered health insurance as having broad potential for development in China. However, most health insurance companies are grappling with revenue from premiums. According to the China Insurance Regulatory Commission statistics, total revenue of the nation's four specialized health insurance companies - PICC Health Insurance, Ping An Health Insurance, Kunlun Health Insurance and Reward Health Insurance - only reached RMB 13.9 billion ($2.09 billion) in the first 11 months of 2008. One inside source revealed that when the health care reform package is not finalized, running a health insurance business is very risky due to the high payout rate. Even so, many insurance firms are gearing up for the sector as CIRC will permit them to invest in insurance-related health care institutions and elderly support entities. (Click here for more - Chinese Language)
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.